Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.
Where this comes from
- Record sourced from PubMed, PMID 42686408.
- Also identified by DOI 10.5694/mja2.70272.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Australia's newborn bloodspot screening (NBS) program is offered to every newborn. It screens for 34 rare conditions with the potential for hundreds more to be added using genomics. Despite NBS being available in Australia since the 1960s, there is a lack of evidence regarding the participation and experiences of Aboriginal and Torres Strait Islander peoples in NBS. As Australia considers a future where genomics might be used in NBS, there is a critical window of opportunity to understand and prioritise the perspectives, hopes and fears of Aboriginal and Torres Strait Islander peoples regarding the utility of genomics in NBS.
Medical subject headings
- Neonatal Screening
- Genomics
- Genetic Testing
- Health Services, Indigenous